# NervGen Pharma Corp. (NGEN): MoatMap facts

As of 13 Nov 2026. Research data, not investment advice.

As of 13 Nov 2026, the MoatMap Score for NervGen Pharma Corp. (NGEN) is 4/100, ranked against 25,000+ stocks in 38 markets (Quality 28, Value 21, Momentum 20, each scored against its sector).

- MoatMap Score: 4/100, a percentile across 25,000+ stocks in 38 markets (100 is best).
- Quality 28, Value 21, Momentum 20: each a 0-100 percentile within Healthcare.
- Position: #25,610 overall, #2,533 in Healthcare.
- Listing: United States, NCM; Healthcare / Biotechnology.
- Last close: 1.63 USD on 12 Nov 2026.
- Insider filings, last 180 days: no director or 5%+ holder trades with a stated value.

Source: https://moatmap.ai/stock/NGEN
How the scores work: https://moatmap.ai/methodology
Does the score work? Each tenth of the ranking is tracked monthly: https://moatmap.ai/decile-tracker